A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formationJohn T. Brandt, Kenneth J. Winters, Stephen D. Wiviott et al.|American Heart Journal|2006Cited by 571
Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose ClopidogrelChristopher D. Payne, Kenneth J. Winters, Joseph A. Jakubowski et al.|Journal of Cardiovascular Pharmacology|2007Cited by 167
The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administrationChristopher D. Payne, Joseph A. Jakubowski, Ying G. Li et al.|Thrombosis and Haemostasis|2008Cited by 120
The Platelet Inhibitory Effects and Pharmacokinetics of Prasugrel After Administration of Loading and Maintenance Doses in Healthy SubjectsJoseph A. Jakubowski, Kenneth J. Winters, Nagy A. Farid et al.|Journal of Cardiovascular Pharmacology|2006Cited by 89
Effect of Atorvastatin on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy SubjectsNagy A. Farid, Kenneth J. Winters, David S. Small et al.|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2008Cited by 87